SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001144204-19-018110
Filing Date
2019-04-04
Accepted
2019-04-04 08:00:32
Documents
13
Effectiveness Date
2019-04-04

Document Format Files

Seq Description Document Type Size
1 DEFM14A tv517046-defm14a.htm DEFM14A 3491010
2 GRAPHIC lg_ampliphi.jpg GRAPHIC 181243
3 GRAPHIC lg_ladenburg.jpg GRAPHIC 44938
4 GRAPHIC sg_ladenburg-thalmann.jpg GRAPHIC 26604
5 GRAPHIC sig_jcook.jpg GRAPHIC 31277
6 GRAPHIC tv511325_chart-table.jpg GRAPHIC 171822
7 GRAPHIC tv511325_img1.jpg GRAPHIC 125674
8 GRAPHIC tv511325_img2.jpg GRAPHIC 91061
9 GRAPHIC tv511325_img3.jpg GRAPHIC 200251
10 GRAPHIC tv511325_proxy1.jpg GRAPHIC 885889
11 GRAPHIC tv511325_proxy2.jpg GRAPHIC 468415
12 GRAPHIC tv511325_proxy3.jpg GRAPHIC 477822
13 GRAPHIC tv511325_proxy4.jpg GRAPHIC 429725
  Complete submission text file 0001144204-19-018110.txt   7798760
Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-37544 | Film No.: 19731213
SIC: 2836 Biological Products, (No Diagnostic Substances)